ZYPHRA RAISES $500M SERIES B AT $5B VALUATION
AI DESK■ 2 MIN READ
TUE, MAY 19, 2026■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE
Zyphra, an AI startup focused on open-weight models running on AMD hardware, is raising $500 million in Series B funding at a valuation of at least $5 billion. AMD is participating in the round.
Zyphra's funding milestone signals growing investor confidence in alternatives to Nvidia-dependent AI infrastructure. The startup specializes in training and inference for open-weight models—AI systems with publicly available parameters—using AMD processors rather than Nvidia's dominant GPU lineup.
The Series B round, led by multiple investors with AMD as a participant, values Zyphra at over $5 billion. The funding reflects a broader market trend toward diversifying AI hardware dependencies and supporting open-source model development.
Zyphra's focus on AMD hardware is strategically significant. As enterprises seek to reduce reliance on Nvidia's expensive GPUs, alternative processors from AMD and other chipmakers present cost and supply-chain advantages. Open-weight models also appeal to companies wanting greater control and transparency over their AI systems compared to closed proprietary models.
The startup joins a wave of AI infrastructure companies attracting massive capital. However, Zyphra's specific positioning around open-weight models and non-Nvidia hardware distinguishes it in a crowded market dominated by larger players like OpenAI, Anthropic, and established chip manufacturers.
AMD's direct participation in the funding round underscores the chipmaker's commitment to competing in AI workloads. Nvidia's dominance in AI training and inference has made partnerships with alternative chip providers increasingly attractive to both investors and enterprises seeking competitive solutions.
The $500 million injection provides Zyphra with substantial resources for scaling operations, expanding its model portfolio, and strengthening its position in the open-weight AI ecosystem. The company will need to demonstrate competitive performance and efficiency advantages to justify its valuation amid intense competition in the AI infrastructure space.
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
12H AGO— AI Desk
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
12H AGO— AI Desk
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
20H AGO— AI Desk
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.
YESTERDAY— Industry Desk